Autoimmune Diseases

Latest News

Tocilizumab-aazg Is First IV, Subcutaneous Tocilizumab Biosimilar With FDA Approval
Tocilizumab-aazg Is First IV, Subcutaneous Tocilizumab Biosimilar With FDA Approval

March 7th 2024

The biosimilar represents a comprehensive, accessible, and high-quality treatment option for patients in the US treated with tocilizumab.

FDA: Simlandi Becomes Third Interchangeable Humira Biosimilar After Approval
FDA: Simlandi Becomes Third Interchangeable Humira Biosimilar After Approval

February 26th 2024

COVID-19 Vaccine Shows Reduced Effect in Patients With RA Receiving DMARDs
COVID-19 Vaccine Shows Reduced Effect in Patients With RA Receiving DMARDs

January 2nd 2024

Slideshow: 2023 Biosimilar Approvals
Slideshow: 2023 Biosimilar Approvals

December 25th 2023

Adalimumab-atto Biosimilar Well Received After Launch
Adalimumab-atto Biosimilar Well Received After Launch

December 6th 2023

Latest CME Events & Activities

Risks and Liabilities in Pharmacy Practice

1.0 Credit / Law

View More

Turning Food Allergy Triggers Into Therapy: A Managed Care Lens on Immunotherapy and Targeted Biologics

1.5 Credits / Immunology

View More

Individualizing Care for Patients With PIDD: The Role of the Pharmacist in Managing Patients on IVIg and SCIg

1.5 Credits / Immunology

View More

Understanding the Role of IVIg and SCIg for the Management of CIDP: Information the Pharmacist Needs to Know to Optimize Care, featuring a Patient Perspective

1.5 Credits / Immunology, Neurology

View More

Targeted Therapies for the Management of Eosinophilic Esophagitis Across the Life Cycle: The Role of the Pharmacist in Patient Identification and Optimization, featuring a Pat...

1.5 Credits / Immunology

View More

Discerning the Significant Burden of Prurigo Nodularis: The Role of Targeted Therapies in Improving Patient Quality of Life, featuring a Patient Perspective

1.5 Credits / Dermatology, Immunology

View More

Reducing the Clinical and Economic Burden of Managing CRSwNP With Emerging Targeted Therapies: A Review for Specialty Pharmacists, featuring a Patient Perspective

1.5 Credits / Immunology

View More

Reducing the Clinical and Caregiver Burden of Moderate to Severe Pediatric Atopic Dermatitis Through Improved Access to Treatments, featuring a Caregiver Perspective

1.5 Credits / Dermatology, Immunology

View More

Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns

1.0 Credit / Law

View More

Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications

1.5 Credits / Law, Oncology

View More

Exploring Targeted Treatment Options for Hereditary Angioedema: Considerations for Pharmacists

1.0 Credit / Immunology

View More

Unveiling the Impact of Childhood Eczema: A Guide to Moderate-Severe Pediatric Atopic Dermatitis

1.0 Credit / Dermatology, Immunology

View More

Revolutionizing Pediatric Atopic Dermatitis Treatment With Targeted Biologics

1.0 Credit / Dermatology, Immunology

View More

Practical Approaches in the Management of Primary Immunodeficiency Disorders: Understanding the Role of Intravenous and Subcutaneous Immunoglobulin

1.0 Credit / Immunology, Rare Diseases

View More

Maximizing the Potential of Biologics in Moderate to Severe Pediatric Atopic Dermatitis: The Expertise of the Specialty Pharmacist

1.0 Credit / Dermatology, Immunology

View More

Managed Care Perspectives on the Burden of Food Allergies and Advances in Treatment

1.5 Credits / Allergy, Immunology

View More

Integrating Biologic Therapy Into Clinical Practice for the Management of Eosinophilic Esophagitis

1.5 Credits / Gastroenterology, Immunology

View More

Best Practices for Optimizing Biologic Therapy Management for Moderate to Severe Atopic Dermatitis in Children

1.5 Credits / Dermatology, Immunology

View More

Child Abuse: Responsibilities and Protection of the Reporter

1.0 Credit / Law

View More

Understanding the Burden of Eosinophilic Esophagitis in Children

1.0 Credit / Gastroenterology, Immunology

View More

The Expertise of the Specialty Pharmacist in Pediatric Eosinophilic Esophagitis

1.0 Credit / Gastroenterology, Immunology

View More

Emerging Biologic Therapy for the Management of Eosinophilic Esophagitis in Children

1.0 Credit / Gastroenterology, Immunology

View More

Optimizing Inflammatory Bowel Disease Treatment: A Pharmacist's Guide to Biologics and Monoclonal Antibodies

1.0 Credits / Gastroenterology, Immunology

View More

Navigating the Complexities of Biologic Therapy for Moderate to Severe Atopic Dermatitis in Children: The Impact of Pharmacists on Patient Care

1.5 Credit / Dermatology, Immunology

View More

More News

© 2024 MJH Life Sciences

All rights reserved.